We demonstrate that ZNF117 can be targeted for GBM treatment in mouse xenograft models through targeted delivery of clustered regularly interspaced short palindromic repeats (CRISPR) machinery via nanoparticles (NPs). The gene discussed is ZNF117; the disease is glioblastoma.